Heron Therapeutics Stock News

First Trust Advisors LP purchased a new position in Heron Therapeutics Inc (NASDAQ:HRTX) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC).

A stock can experience a pullback for a variety of reasons, be it disappointing quarterly results, the impact of internal politics, or the effect of the coronavirus on the economy. Yet, traditionally,

A stock can experience a pullback for a variety of reasons, be it disappointing quarterly results, the impact of internal politics, or the effect of the

The Zacks Analyst Blog Highlights: Moderna, Incyte, Heron Therapeutics and NGM Biopharmaceuticals

The Zacks Analyst Blog Highlights: Moderna, Incyte, Heron Therapeutics and NGM Biopharmaceuticals

The biotech sector was in focus with pipeline updates from a few small biotech companies.

The biotech sector was in focus with pipeline updates from a few small biotech companies.

The "CINV Treatment Market - Growth, Trends, and Forecast (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering.

VerdePharmHealth, a cannabis group purchasing organization (VerdePharm GPO) coupled with a clinical education & healthcare technology solutions business (VerdePharm Solutions), today announces the app

Dublin, Feb. 26, 2020 -- The "CINV Treatment Market - Growth, Trends, and Forecast (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering..

So far Tuesday, February 25, NASDAQ is down -5.98% and the S&P is down -5.61%. Here are this morning’s most

Heron Therapeutics' 2 commercialised drugs for the treatment of acute and delayed nausea and vomiting associated with types of chemotherapy are under pressure f

American International Group Inc. boosted its position in shares of Heron Therapeutics Inc (NASDAQ:HRTX) by 12.9% in the 4th quarter, according to its most recent disclosure with the Securities & Exch